Coimmune

Manufacturer of cytokine agents for treating cancer

placeDurham, North Carolina, United States calendar_todayFounded 2019 groups47 employees language coimmune.com

Registered entities

Innovation

22 patent families (15 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Operations & transport; filing pace slowing. Cited 324 times.

YearFilings
20124
20132
20141
20163
20171
20181
20192
20204
20217
20225
20233

Investor mix

4 investors on record; lead investors include Array.

Investor typeCountShare
Venture capital250%
Bank & private debt125%
Other / undisclosed125%
Coming soon